Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 02-2017 | 11-2016 | 08-2016 | 05-2016 | 02-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,734 | 2,566 | 8,626 | 9,894 | 8,214 |
| Receivables | 45,918 | 50,009 | 44,150 | 46,406 | 42,924 |
| Inventories | 23,273 | 27,970 | 30,182 | 25,535 | 27,161 |
| TOTAL | $86,575 | $84,475 | $87,773 | $86,303 | $83,905 |
| Non-Current Assets | |||||
| PPE Net | 123,005 | 120,972 | 120,720 | 120,880 | 108,719 |
| Investments And Advances | 63,400 | 62,700 | 62,700 | 62,700 | 62,500 |
| Intangibles | 70,352 | 70,573 | 70,795 | 71,016 | 71,237 |
| Other Non-Current Assets | 2,804 | 2,621 | 1,784 | 1,754 | 2,316 |
| TOTAL | $259,561 | $256,866 | $255,999 | $256,350 | $244,772 |
| Total Assets | $346,136 | $341,341 | $343,772 | $342,653 | $328,677 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,940 | 6,440 | 7,930 | 11,373 | 8,546 |
| Accounts payable and accrued liabilities | 24,764 | 25,914 | 31,613 | 30,904 | 25,091 |
| Accrued Expenses | 6,136 | 5,696 | 4,045 | 5,460 | 4,206 |
| TOTAL | $47,173 | $46,948 | $53,433 | $56,341 | $46,356 |
| Non-Current Liabilities | |||||
| Long Term Debt | 43,534 | 44,771 | 44,066 | 45,972 | 48,607 |
| Deferred Revenues | 429 | 474 | 706 | 832 | 1,152 |
| Other Non-Current Liabilities | 2,025 | 1,929 | 1,956 | 1,744 | 1,705 |
| TOTAL | $74,823 | $74,846 | $73,388 | $73,962 | $75,715 |
| Total Liabilities | $121,996 | $121,794 | $126,821 | $130,303 | $122,071 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,305 | 27,271 | 27,241 | N/A | 27,073 |
| Common Shares | 27 | 27 | 27 | 27 | 27 |
| Retained earnings | 82,018 | 78,518 | 77,192 | 73,457 | 68,728 |
| Other shareholders' equity | 1,961 | 1,864 | 1,655 | 1,622 | 1,548 |
| TOTAL | $224,140 | $219,547 | $216,951 | $212,350 | $206,606 |
| Total Liabilities And Equity | $346,136 | $341,341 | $343,772 | $342,653 | $328,677 |